2019
DOI: 10.1097/pai.0000000000000526
|View full text |Cite
|
Sign up to set email alerts
|

New Tool for Monitoring Molecular Response in Patients With Chronic Myeloid Leukemia

Abstract: In this pilot study, SNAQ methodology performed consistent with half-log accuracy. Additional studies from a larger sample size and correlation with clinical outcomes are required to confirm this observation.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 13 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?